Kyler Obrien

Kyler O'Brien currently serves as Corporate Counsel at Blackrock Microsystems, Inc., a leading innovator in the life sciences and MedTech sectors. In this strategic legal role, Kyler plays a pivotal part in supporting the company's growth and technological advancement by providing comprehensive legal guidance across a broad spectrum of corporate, commercial, and regulatory matters. His expertise is instrumental in negotiating complex SaaS agreements, licensing arrangements, and vendor contracts that underpin Blackrock’s cutting-edge research and clinical products. Kyler’s deep understanding of healthcare technology, privacy, and compliance issues ensures that the company remains aligned with evolving industry standards and regulatory frameworks, including HIPAA and FDA regulations.

A key focus of Kyler’s work involves advising product development teams on legal considerations related to clinical and research technologies, helping to shape product strategy while mitigating legal risks. His role also encompasses drafting and reviewing Terms of Use, End-User License Agreements (EULAs), and Privacy Policies, ensuring that Blackrock’s digital platforms and research collaborations adhere to best practices in data security and user privacy. Additionally, Kyler supports the company’s capital raising initiatives by providing legal counsel on securities compliance and investor agreements, facilitating smooth financial transactions.

With over eight years of experience, Kyler’s skill set extends to operations management, contract management, and civil litigation, complemented by his knowledge of medical device law and research. His collaborative approach and strategic insight enable him to work effectively with cross-functional teams, ensuring legal robustness while fostering innovation in the rapidly evolving MedTech landscape.